This technology, developed by Prof. Dvir, is currently under development by Matricelf. Matricelf licensed the technology that enabled printing the first functioning 3D human heart from cells and matrix derived from a human omentum biopsy. Prof. Dvir serves as Matricelf's Chief Scientist.
Prof. Tal Dvir's research has been supported by the Zimin Institute at TAU for Engineering Solutions Advancing Better Lives. In 2019, Prof Tal Dvir was selected as one of the 20 promising Israeli scientists for the new decade.